Trial Profile
A Study to Evaluate the Efficacy and Safety of Ledipasvir/Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 1 Infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 May 2016
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 16 May 2016 New trial record
- 17 Apr 2016 Results (n = 1778) presented at The International Liver Congress™ 2016